Current Liabilities
Operating Lease Liability Payments - 2024 (Lessee)
Neurocrine Biosciences Operating Lease Liability Payments - 2024 (Lessee) increased by 0.2% to $59.7M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.8%, from $59.2M to $59.7M.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ2 2020
Last reportedQ1 2026May 5, 2026
Metric ID:
lease_liability_payments_2024_lesseeHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.5M | $17.5M | $17.4M | $17.4M | $17.4M | $15.9M | $17M | $17M | $34M | $34.9M | $34.9M | $59.2M | $59.2M | $59.6M | $59.7M |
| QoQ Change | — | +0.0% | -0.6% | +0.0% | +0.0% | -8.6% | +6.9% | +0.0% | +100.0% | +2.6% | +0.0% | +69.6% | +0.0% | +0.7% | +0.2% |
| YoY Change | — | — | — | -0.6% | -0.6% | -8.6% | -2.3% | -2.3% | +113.8% | +105.3% | +105.3% | +74.1% | +69.6% | +70.8% | +0.8% |
Range$15.9M – $59.7M
CAGR+42.0%
Avg YoY Growth+43.8%
Median YoY Growth+35.2%
Current Streak9 quarters growth
Operating Lease Liability Payments - 2024 (Lessee) at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's operating lease liability payments - 2024 (lessee)?
- Neurocrine Biosciences (NBIX) reported operating lease liability payments - 2024 (lessee) of $59.7M in Q1 2026.
- How has Neurocrine Biosciences's operating lease liability payments - 2024 (lessee) changed year-over-year?
- Neurocrine Biosciences's operating lease liability payments - 2024 (lessee) increased by 0.8% year-over-year, from $59.2M to $59.7M.